Logo image of PHM7.DE

ALTRIA GROUP INC (PHM7.DE) Stock Fundamental Analysis

Europe - FRA:PHM7 - US02209S1033 - Common Stock

56.31 EUR
-0.41 (-0.72%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PHM7. PHM7 was compared to 4 industry peers in the Tobacco industry. PHM7 has an excellent profitability rating, but there are some minor concerns on its financial health. PHM7 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

PHM7 had positive earnings in the past year.
In the past year PHM7 had a positive cash flow from operations.
Each year in the past 5 years PHM7 has been profitable.
Each year in the past 5 years PHM7 had a positive operating cash flow.
PHM7.DE Yearly Net Income VS EBIT VS OCF VS FCFPHM7.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

PHM7 has a better Return On Assets (27.10%) than 100.00% of its industry peers.
PHM7's Return On Invested Capital of 37.10% is amongst the best of the industry. PHM7 outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PHM7 is significantly above the industry average of 21.21%.
The 3 year average ROIC (34.16%) for PHM7 is below the current ROIC(37.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 27.1%
ROE N/A
ROIC 37.1%
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.16%
ROIC(5y)31.32%
PHM7.DE Yearly ROA, ROE, ROICPHM7.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

PHM7's Profit Margin of 37.13% is amongst the best of the industry. PHM7 outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of PHM7 has grown nicely.
With an excellent Operating Margin value of 51.20%, PHM7 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of PHM7 has grown nicely.
PHM7 has a Gross Margin of 61.41%. This is comparable to the rest of the industry: PHM7 outperforms 50.00% of its industry peers.
PHM7's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 51.2%
PM (TTM) 37.13%
GM 61.41%
OM growth 3Y2.51%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.67%
GM growth 5Y3.35%
PHM7.DE Yearly Profit, Operating, Gross MarginsPHM7.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHM7 is creating value.
Compared to 1 year ago, PHM7 has less shares outstanding
PHM7 has less shares outstanding than it did 5 years ago.
PHM7 has a worse debt/assets ratio than last year.
PHM7.DE Yearly Shares OutstandingPHM7.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
PHM7.DE Yearly Total Debt VS Total AssetsPHM7.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

An Altman-Z score of 5.22 indicates that PHM7 is not in any danger for bankruptcy at the moment.
The Altman-Z score of PHM7 (5.22) is better than 100.00% of its industry peers.
PHM7 has a debt to FCF ratio of 2.83. This is a good value and a sign of high solvency as PHM7 would need 2.83 years to pay back of all of its debts.
PHM7's Debt to FCF ratio of 2.83 is amongst the best of the industry. PHM7 outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.83
Altman-Z 5.22
ROIC/WACC4.86
WACC7.64%
PHM7.DE Yearly LT Debt VS Equity VS FCFPHM7.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

A Current Ratio of 0.39 indicates that PHM7 may have some problems paying its short term obligations.
The Current ratio of PHM7 (0.39) is worse than 75.00% of its industry peers.
PHM7 has a Quick Ratio of 0.39. This is a bad value and indicates that PHM7 is not financially healthy enough and could expect problems in meeting its short term obligations.
PHM7's Quick ratio of 0.24 is on the low side compared to the rest of the industry. PHM7 is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.24
PHM7.DE Yearly Current Assets VS Current LiabilitesPHM7.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.54% over the past year.
PHM7 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.03% yearly.
The Revenue has decreased by -1.86% in the past year.
Measured over the past years, PHM7 shows a decrease in Revenue. The Revenue has been decreasing by -0.89% on average per year.
EPS 1Y (TTM)8.54%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%9.92%
Revenue 1Y (TTM)-1.86%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%0.25%

3.2 Future

Based on estimates for the next years, PHM7 will show a small growth in Earnings Per Share. The EPS will grow by 3.90% on average per year.
PHM7 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.48% yearly.
EPS Next Y9.18%
EPS Next 2Y6.13%
EPS Next 3Y5.27%
EPS Next 5Y3.9%
Revenue Next Year-0.72%
Revenue Next 2Y-0.26%
Revenue Next 3Y-0.22%
Revenue Next 5Y0.48%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHM7.DE Yearly Revenue VS EstimatesPHM7.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
PHM7.DE Yearly EPS VS EstimatesPHM7.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.32, PHM7 is valued correctly.
PHM7's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, PHM7 is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.39, the valuation of PHM7 can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHM7 is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, PHM7 is valued a bit cheaper.
Industry RankSector Rank
PE 12.32
Fwd PE 11.39
PHM7.DE Price Earnings VS Forward Price EarningsPHM7.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHM7 indicates a somewhat cheap valuation: PHM7 is cheaper than 75.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHM7 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.66
EV/EBITDA 10.9
PHM7.DE Per share dataPHM7.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

PHM7's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHM7 may justify a higher PE ratio.
PEG (NY)1.34
PEG (5Y)3.06
EPS Next 2Y6.13%
EPS Next 3Y5.27%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.37%, PHM7 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.40, PHM7 pays a better dividend. On top of this PHM7 pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, PHM7 pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.37%

5.2 History

The dividend of PHM7 has a limited annual growth rate of 4.03%.
Dividend Growth(5Y)4.03%
Div Incr Years6
Div Non Decr Years6
PHM7.DE Yearly Dividends per sharePHM7.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

PHM7 pays out 78.52% of its income as dividend. This is not a sustainable payout ratio.
The dividend of PHM7 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP78.52%
EPS Next 2Y6.13%
EPS Next 3Y5.27%
PHM7.DE Yearly Income VS Free CF VS DividendPHM7.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
PHM7.DE Dividend Payout.PHM7.DE Dividend Payout, showing the Payout Ratio.PHM7.DE Dividend Payout.PayoutRetained Earnings

ALTRIA GROUP INC

FRA:PHM7 (9/12/2025, 7:00:00 PM)

56.31

-0.41 (-0.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners63.51%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap94.59B
Analysts71.3
Price Target53.29 (-5.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.37%
Yearly Dividend3.39
Dividend Growth(5Y)4.03%
DP78.52%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.73%
Min EPS beat(2)0.61%
Max EPS beat(2)0.84%
EPS beat(4)2
Avg EPS beat(4)-0.51%
Min EPS beat(4)-2.78%
Max EPS beat(4)0.84%
EPS beat(8)2
Avg EPS beat(8)-2.07%
EPS beat(12)2
Avg EPS beat(12)-2.44%
EPS beat(16)2
Avg EPS beat(16)-2.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-4.94%
Max Revenue beat(2)-0.92%
Revenue beat(4)0
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-4.94%
Max Revenue beat(4)-0.92%
Revenue beat(8)0
Avg Revenue beat(8)-3.41%
Revenue beat(12)3
Avg Revenue beat(12)1.03%
Revenue beat(16)7
Avg Revenue beat(16)5.21%
PT rev (1m)4.58%
PT rev (3m)2.03%
EPS NQ rev (1m)0.37%
EPS NQ rev (3m)0.06%
EPS NY rev (1m)1%
EPS NY rev (3m)0.89%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 12.32
Fwd PE 11.39
P/S 4.68
P/FCF 12.66
P/OCF 12.45
P/B N/A
P/tB N/A
EV/EBITDA 10.9
EPS(TTM)4.57
EY8.12%
EPS(NY)4.94
Fwd EY8.78%
FCF(TTM)4.45
FCFY7.9%
OCF(TTM)4.52
OCFY8.03%
SpS12.02
BVpS-1.66
TBVpS-11.32
PEG (NY)1.34
PEG (5Y)3.06
Profitability
Industry RankSector Rank
ROA 27.1%
ROE N/A
ROCE 47.29%
ROIC 37.1%
ROICexc 39.06%
ROICexgc 179.29%
OM 51.2%
PM (TTM) 37.13%
GM 61.41%
FCFM 36.99%
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.16%
ROIC(5y)31.32%
ROICexc(3y)39.35%
ROICexc(5y)36.18%
ROICexgc(3y)239.24%
ROICexgc(5y)176.2%
ROCE(3y)43.55%
ROCE(5y)39.93%
ROICexcg growth 3Y38.33%
ROICexcg growth 5Y47.52%
ROICexc growth 3Y4.11%
ROICexc growth 5Y13.18%
OM growth 3Y2.51%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.67%
GM growth 5Y3.35%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.83
Debt/EBITDA 1.91
Cap/Depr 51.21%
Cap/Sales 0.63%
Interest Coverage 250
Cash Conversion 71.75%
Profit Quality 99.62%
Current Ratio 0.39
Quick Ratio 0.24
Altman-Z 5.22
F-Score6
WACC7.64%
ROIC/WACC4.86
Cap/Depr(3y)70.81%
Cap/Depr(5y)74.31%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.75%
Profit Quality(3y)109.56%
Profit Quality(5y)169.16%
High Growth Momentum
Growth
EPS 1Y (TTM)8.54%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%9.92%
EPS Next Y9.18%
EPS Next 2Y6.13%
EPS Next 3Y5.27%
EPS Next 5Y3.9%
Revenue 1Y (TTM)-1.86%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%0.25%
Revenue Next Year-0.72%
Revenue Next 2Y-0.26%
Revenue Next 3Y-0.22%
Revenue Next 5Y0.48%
EBIT growth 1Y4.83%
EBIT growth 3Y-0.18%
EBIT growth 5Y2.09%
EBIT Next Year6.39%
EBIT Next 3Y3.82%
EBIT Next 5Y2.35%
FCF growth 1Y1.75%
FCF growth 3Y1.5%
FCF growth 5Y2.55%
OCF growth 1Y0.83%
OCF growth 3Y1.36%
OCF growth 5Y2.24%